I use this page to record validation evidence for Temple’s BrainFlow measurements, including the methods, results, limitations, and replication plans reported in the announcements.
I announced, “Temple's first validation study is out.”
The first validation study used a head-to-head comparison with Transcranial Doppler (TCD), described as the gold standard for measuring cerebrovascular function.
The first study included 23 healthy adults and two challenges: cycling and a standing-to-supine postural shift.
During the postural shift, heart rate dropped while brain blood flow went up; Temple tracked this accurately alongside the Doppler.
I pointed out that “Any device that only measures heart rate would have gotten this completely wrong.”
Across both challenges, Temple's Brain Flow tracked Middle Cerebral Artery velocity (MCAv) with within-subject temporal correlation of r≈0.8 (p<0.001).
I characterized the correlation as “very high even for medical devices.”
The first paper was a preprint submitted for peer review.
I described the initial evidence limit as: “One study, two interventions, healthy adults only”.
I said further validations of Brain Flow and Entropy using different modalities were underway across the globe.
I encourage researchers to replicate the work and offer to loan Temples to qualified researchers who want to pressure-test our metrics independently.
The first announcement presents the postural-shift result as a reason heart rate alone is insufficient: heart rate moved in the opposite direction from brain blood flow. The study was an initial validation, not evidence of results beyond its tested population and challenges.
In a second validation study, I reported testing Temple BrainFlow against time-domain NIRS, which can separate brain blood volume changes from scalp blood volume changes.
The second study included 60 participants and three physiological challenges: head-down tilt, stand-to-squat, and stand-to-supine.
Across all three challenges, Temple BrainFlow tracked brain blood volume at r=0.84-0.91, significantly more than scalp blood volume.
For head-down tilt, Temple's correlation with the brain was 0.91, and scalp correlation was just 0.49.
My takeaway from the second validation was: “Temple tracks the brain, much more than the scalp.”
I described Cerebral Blood Flow as rising with aerobic exercise and said VO2max correlates directly with it.
I said Cerebral Blood Flow rises with cold exposure and meditation, is sustained by better sleep, and drops with prolonged sitting and dehydration.
I described Cerebral Blood Flow as “one of the most responsive and integrative biomarkers of how well your body is actually running, and aging.”
I said, “Until now, you could only measure it in a clinical setting, in a single snapshot.”
I said, “Temple measures it continuously, in real time, while you live your life.”
I claimed Temple was, “as of today, the only wearable in the world with validations against brain blood volume, and not just scalp.”
I said the second validation was Temple BrainFlow’s second validated modality, following Transcranial Doppler.
I reported that the second paper was posted as a preprint and submitted for peer review.
I said the second study was guided by Scientific Advisor Prof. David Boas, Director of Boston University's Neurophotonics Center.
A separate reply to my second-study announcement said “More details:” and linked to additional information; it does not independently establish further study results.
The second announcement also invites independent replication and offers device loans to qualified researchers. The reported findings remain preprint results; the posts do not provide independent replication outcomes or establish generalization beyond the described studies.
In my September 25 second validation study, I compared Temple BrainFlow with time-domain NIRS, which I described as able to separate brain blood-volume changes from scalp blood-volume changes.
I reported that 60 participants completed three physiological challenges: head-down tilt, stand-to-squat, and stand-to-supine.
For head-down tilt, I reported Temple's correlation with brain blood volume was 0.91, compared with a scalp correlation of 0.49.
I said this validation was guided by our Scientific Advisor, Prof. David Boas, Director of Boston University's Neurophotonics Center.
I said the paper was posted as a preprint and submitted for peer review, and that we encourage researchers to replicate the study and will happily loan Temples to qualified researchers for independent pressure-testing.
In my November 1 heart-rate comparison, I said, “We benchmarked five flagship wearables against that reference, from rest to max effort, second by second.”
I explained the taped Polar H10 reference this way: “Taped, because worn the usual way, straps lose contact mid-sprint and miss beats.”
I reported, “Apple Watch Series 12 came closest.”
I also said, “Temple also beat the untaped chest strap, the industry's benchmark, in zones 4 and 5.”
I explained Temple’s sensor placement and adhesive by saying, “Temple uses adhesive, so its lab condition is its wear condition.”
I said, “We tested the same sensor at four body sites. The temple was the most accurate of the four.”
I said, “and an extended study by independent researchers is underway.” I also invited further independent replication in more conditions and said Temple would fund it.
In my November 2 retake, I stated: “Temple tracks heart rate more accurately than standard-wear ECG chest straps in Zones 4 & 5.”
I said, “We therefore taped the chest strap to each participant to avoid any drops due to motion or contact loss, which worked.”
I taped the chest strap to each participant to avoid any drops due to motion or contact loss, which worked.
I said Temple was by far the most accurate wearable amongst everything we studied.
I said our goal is to become the new reference.
I pointed readers to t.pw/hr; More independent validations are underway.
I invited athletes seeking a training edge to email athletes@temple.com; temple.com.
I said, “At Temple, our goal is to become the new reference.”
I said, “Skeptics are urged to wait before buying.” I invited athletes seeking a training edge to write to athletes@temple.com.
I said, “Btw, I am tempted to follow the global standards set by Apple and not offer our current 14-day no-questions-asked return policy in India. I will sleep over it.” This was a consideration, not an announced policy change.
A separate November 1 post claimed: “Temple is the most accurate HR tracker compared to all flagship wearables, even in Zone 4 & 5.” It pointed readers to a detailed study.
Related: meditation and brain health, health tracking metrics, brain blood flow mechanism